A new type of bone marrow transplant can cure sickle cell disease with only half of the donor's cell proteins matching, ...
Sickle cell disease (SCD), the most common inherited blood disorder, affects millions worldwide. In the United States alone, ...
ROCHESTER, N.Y. – Researchers at Golisano Children’s Hospital have received a multi-million-dollar grant to lead a ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...